GlassScriptPhysician profile
David S German
NPI 1598776601
$2,388.11
in general payments reported to CMS, 2019-2025
13 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $30.41 · 2021: $191 · 2022: $213 · 2023: $731 · 2024: $777 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $996.06 | 2019-2025 | Puraply, Puraply Wound Matrix, Affinity |
| Smith+Nephew, INC. | $686.44 | 2019-2025 | Collagenase Santyl, Regranex, Grafix Pl |
| Ets Wound Care LLC | $144.75 | 2023-2025 | Mirragen Advanced Wound Matrix |
| Molnlycke Health Care US, LLC | $132.13 | 2022 | |
| Convatec INC. | $114.91 | 2024 | |
| Hydrofera LLC | $101.02 | 2023-2025 | Hydrofera Blue |
| Kci USA, INC. | $56.05 | 2021-2023 | Activ.A.C., V.A.C. Dermatac |
| Solventum Corporation | $50.65 | 2024-2025 | Activ.A.C., V.A.C. Veraflo, 3m Coban |
| Integra Lifesciences Corporation | $38.01 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acera Surgical, INC. | $21.87 | 2021 | |
| Janssen Biotech, INC. | $21.16 | 2019 | |
| Tactile Systems Technology INC | $13.88 | 2025 | Nimbl, Flexitouch Plus |
| Paratek Pharmaceuticals, INC. | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David German listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.